Search results
25 sty 2023 · Bivalent boosters provided substantial additional protection against severe omicron infection in persons who had previously been vaccinated or boosted, although the effectiveness waned over...
- Correspondence May 4, 2023 Bivalent Boosters Against Severe Omicron Infection
To the Editor: Lin and colleagues (Feb. 23 issue)1 report...
- Images in Clinical Medicine Pseudothrombocytosis K. Liapis and S. Papadakis
An 80-year-old woman who had been admitted with severe burns...
- Perspective The Princess and The He B.M. Reilly
A retired physician volunteers to help teach bedside skills...
- Editorial Hemophilia a Gene Therapy — Some Answers, More Questions L.A. George
Hemophilia A is an X-linked disorder caused by the loss of...
- Perspective Fraud, Abuse, and Financial Conflicts of Interest Z. Buck
Increased attention and ever-growing complexity in the area...
- Perspective Protecting The Legitimacy of Medical Expertise R.J. Baron and C.H. Coleman
Amid the Covid-19 pandemic, state lawmakers have embraced...
- Correspondence May 4, 2023 Bivalent Boosters Against Severe Omicron Infection
22 wrz 2021 · First results from any randomized, controlled COVID-19 vaccine booster trial demonstrate a relative vaccine efficacy of 95.6% against disease during a period when Delta was the prevalent strain; In trial with more than 10,000 participants 16 years of age and older, COVID-19 booster was found to have a favorable safety profile
8 lip 2021 · update on their comprehensive booster strategy. Pfizer and BioNTech have seen encouraging data in the ongoing booster trial of a third dose of the current BNT162b2 vaccine.
2 lip 2024 · Johns Hopkins Medicine research finds booster doses of bivalent vaccines given every three to six months helps maintain a person’s ability to neutralize multiple SARS-CoV-2 strains, including XBB.1.5.
13 wrz 2023 · The new boosters are a much closer match to currently circulating variants than prior vaccines, say federal health officials. They're updated versions of the existing Moderna and...
8 gru 2021 · Pfizer and BioNTech have said a booster jab of their coronavirus vaccine promises to be an effective defence against the new Omicron variant. Three doses provide a similar level of antibodies...
14 sty 2022 · Using evidence from the COV-BOOST trial, which demonstrated that the mRNA vaccines provide a strong booster effect with low reactogenicity, regardless of the vaccine given in the primary course...
